Who can use Epclusa(Sofosbuvir and Velpatasvir Tablets‌)?

The conditions and patient populations for which EPCLUSA is approved.

Indications for Use

EPCLUSA is indicated for the treatment of adult and pediatric patients (3 years and older) with chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection. It is used in patients without cirrhosis or with compensated cirrhosis. For patients with decompensated cirrhosis, EPCLUSA is used in combination with another antiviral drug called ribavirin to achieve the therapeutic goal.